Register for More Information

Register Now

Find a Treatment Center

Enter your state or zip code to find a THERAKOSTM Photopheresis treatment center near you

Talk to your doctor to determine if treatment is right for you

 
 

Patients & Caregivers

Living with cutaneous T-cell lymphoma (CTCL) can be a challenge, but it’s a challenge that Therakos, Inc. is committed to helping you meet.

If you’ve been diagnosed with CTCL—or if someone you know has—this Web site is for you. Here you’ll find useful information on CTCL, and you’ll learn about a therapy designed to reduce the skin symptoms associated with the disorder: THERAKOS™ Photopheresis.

You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Patient Landing Right Menu Block

 
 

Important Safety Information

Indications

Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS UVAR XTS® or THERAKOS CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.

Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.

THERAKOS Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.

 

All contents Copyright © Therakos, Inc. 2001-2014.

This site is published by Therakos, Inc. which is solely responsible for its contents.

It is intended for visitors from the United States of America.